170 related articles for article (PubMed ID: 14983520)
1. Monastrol, a prototype anti-cancer drug that inhibits a mitotic kinesin, induces rapid bursts of axonal outgrowth from cultured postmitotic neurons.
Haque SA; Hasaka TP; Brooks AD; Lobanov PV; Baas PW
Cell Motil Cytoskeleton; 2004 May; 58(1):10-6. PubMed ID: 14983520
[TBL] [Abstract][Full Text] [Related]
2. Monastrol, a selective inhibitor of the mitotic kinesin Eg5, induces a distinctive growth profile of dendrites and axons in primary cortical neuron cultures.
Yoon SY; Choi JE; Huh JW; Hwang O; Lee HS; Hong HN; Kim D
Cell Motil Cytoskeleton; 2005 Apr; 60(4):181-90. PubMed ID: 15751098
[TBL] [Abstract][Full Text] [Related]
3. Kinesin-5 Blocker Monastrol Protects Against Bortezomib-Induced Peripheral Neurotoxicity.
Bobylev I; Peters D; Vyas M; Barham M; Klein I; von Strandmann EP; Neiss WF; Lehmann HC
Neurotox Res; 2017 Nov; 32(4):555-562. PubMed ID: 28612296
[TBL] [Abstract][Full Text] [Related]
4. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5.
Kapoor TM; Mayer TU; Coughlin ML; Mitchison TJ
J Cell Biol; 2000 Sep; 150(5):975-88. PubMed ID: 10973989
[TBL] [Abstract][Full Text] [Related]
5. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5.
Maliga Z; Kapoor TM; Mitchison TJ
Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein.
Peters T; Lindenmaier H; Haefeli WE; Weiss J
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):291-9. PubMed ID: 16365780
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.
DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F
Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint.
Chin GM; Herbst R
Mol Cancer Ther; 2006 Oct; 5(10):2580-91. PubMed ID: 17041103
[TBL] [Abstract][Full Text] [Related]
9. New chemical tools for investigating human mitotic kinesin Eg5.
Klein E; DeBonis S; Thiede B; Skoufias DA; Kozielski F; Lebeau L
Bioorg Med Chem; 2007 Oct; 15(19):6474-88. PubMed ID: 17587586
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologically inhibiting kinesin-5 activity with monastrol promotes axonal regeneration following spinal cord injury.
Xu C; Klaw MC; Lemay MA; Baas PW; Tom VJ
Exp Neurol; 2015 Jan; 263():172-6. PubMed ID: 25447935
[TBL] [Abstract][Full Text] [Related]
11. Monastrol inhibition of the mitotic kinesin Eg5.
Cochran JC; Gatial JE; Kapoor TM; Gilbert SP
J Biol Chem; 2005 Apr; 280(13):12658-67. PubMed ID: 15665380
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the human kinesin Eg5 that confer resistance to monastrol and S-trityl-L-cysteine in tumor derived cell lines.
Tcherniuk S; van Lis R; Kozielski F; Skoufias DA
Biochem Pharmacol; 2010 Mar; 79(6):864-72. PubMed ID: 19896928
[TBL] [Abstract][Full Text] [Related]
13. Mitotic slippage and expression of survivin are linked to differential sensitivity of human cancer cell-lines to the Kinesin-5 inhibitor monastrol.
Asraf H; Avunie-Masala R; Hershfinkel M; Gheber L
PLoS One; 2015; 10(6):e0129255. PubMed ID: 26035434
[TBL] [Abstract][Full Text] [Related]
14. Development and biological evaluation of potent and specific inhibitors of mitotic Kinesin Eg5.
Gartner M; Sunder-Plassmann N; Seiler J; Utz M; Vernos I; Surrey T; Giannis A
Chembiochem; 2005 Jul; 6(7):1173-7. PubMed ID: 15912555
[No Abstract] [Full Text] [Related]
15. Kinesin-5, a mitotic microtubule-associated motor protein, modulates neuronal migration.
Falnikar A; Tole S; Baas PW
Mol Biol Cell; 2011 May; 22(9):1561-74. PubMed ID: 21411631
[TBL] [Abstract][Full Text] [Related]
16. Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells.
Marcus AI; Peters U; Thomas SL; Garrett S; Zelnak A; Kapoor TM; Giannakakou P
J Biol Chem; 2005 Mar; 280(12):11569-77. PubMed ID: 15653676
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
Müller C; Gross D; Sarli V; Gartner M; Giannis A; Bernhardt G; Buschauer A
Cancer Chemother Pharmacol; 2007 Feb; 59(2):157-64. PubMed ID: 16703323
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function.
Ari C; Borysov SI; Wu J; Padmanabhan J; Potter H
Neurobiol Aging; 2014 Aug; 35(8):1839-49. PubMed ID: 24636920
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Kinesin-5, a microtubule-based motor protein, as a strategy for enhancing regeneration of adult axons.
Lin S; Liu M; Son YJ; Timothy Himes B; Snow DM; Yu W; Baas PW
Traffic; 2011 Mar; 12(3):269-86. PubMed ID: 21166743
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition.
Luo L; Carson JD; Dhanak D; Jackson JR; Huang PS; Lee Y; Sakowicz R; Copeland RA
Biochemistry; 2004 Dec; 43(48):15258-66. PubMed ID: 15568818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
